Division of Public Health, Center for Community Medicine, Jichi Medical University, Yakushiji 3311-1, Shimotsuke, Tochigi, 329-0498, Japan.
Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Pediatr Cardiol. 2021 Apr;42(4):969-977. doi: 10.1007/s00246-021-02571-8. Epub 2021 Mar 8.
A giant coronary artery (CA) aneurysm is a potentially fatal cardiac complication resulting from Kawasaki disease (KD). We aimed to identify epidemiologic characteristics and potential risk factors associated with giant CA aneurysms identified after acute KD. We analyzed 90,252 patients diagnosed with KD from 2011 to 2018, using data obtained in nationwide KD surveys conducted in Japan. Multivariable logistic regression analyses were performed to evaluate potential risk factors associated with subsequent giant CA aneurysm complications (defined as lumen size ≥ 8 mm), adjusting for all potential factors. Giant CA aneurysms were identified in 144 patients (0.16%) after acute KD. The annual prevalence ranged from 0.07 to 0.20% during the study period. In the multivariate analyses, male sex (adjusted odds ratio 2.09 [95% confidence interval 1.41-3.11], recurrent KD (1.90 [1.09-3.33]), IVIG administration at 1-4 days of illness (1.49 [1.04-2.15]) and ≥ 8 days after KD onset (2.52 [1.38-4.60]; reference, 5-7 days), detection of CA dilatations and aneurysms at initial echocardiography (4.17 [1.85-5.41] and 46.5 [28.8-74.8], respectively), and resistance to IVIG treatment (6.09 [4.23-8.75]) were significantly associated with giant CA aneurysm complications identified after acute KD. The annual prevalence of giant CA aneurysms identified after acute KD did not increase during the study period. Patients with larger CA abnormalities detected at initial echocardiography were independently associated with progression to giant CA aneurysm complications after acute KD regardless of the number of days from onset at treatment initiation.
巨大冠状动脉(CA)动脉瘤是川崎病(KD)导致的一种潜在致命性心脏并发症。本研究旨在确定 KD 后发生的巨大 CA 动脉瘤的流行病学特征和潜在危险因素。我们分析了 2011 年至 2018 年在日本进行的全国性 KD 调查中诊断为 KD 的 90252 例患者的数据。采用多变量逻辑回归分析评估与随后发生巨大 CA 动脉瘤并发症(定义为管腔大小≥8mm)相关的潜在危险因素,调整了所有潜在因素。在 KD 后急性发作后,有 144 例(0.16%)患者出现巨大 CA 动脉瘤。在研究期间,每年的患病率范围为 0.07%至 0.20%。在多变量分析中,男性(调整比值比[OR]2.09[95%置信区间[CI]1.41-3.11])、KD 复发(1.90[1.09-3.33])、发病后 1-4 天(1.49[1.04-2.15])和≥8 天(2.52[1.38-4.60])接受 IVIG 治疗(参考为 5-7 天)、初次超声心动图检查时发现 CA 扩张和动脉瘤(4.17[1.85-5.41]和 46.5[28.8-74.8])以及 IVIG 治疗耐药(6.09[4.23-8.75])与 KD 后急性发作后发生巨大 CA 动脉瘤并发症显著相关。KD 后急性发作后发现巨大 CA 动脉瘤的年患病率在研究期间并未增加。初次超声心动图检查时发现的 CA 异常较大的患者与 KD 后急性发作后进展为巨大 CA 动脉瘤并发症独立相关,而与治疗开始时从发病到开始治疗的天数无关。